Stemline Therapeutics Stock Predictions

Buy STML

*Your capital is at risk

$11.83

+0 (+0%)

At Close: Sep 04, 2020

Currently predicting for Wed, 10 Jun 2026

STML Live board

Community Bull/Bear

Target Next close

Join the STML prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

STML Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For STML

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

STML Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT STEMLINE THERAPEUTICS

Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of proprietary oncology therapeutics in the United States. It develops SL-401, a targeted therapy directed to the interleukin-3 receptor (IL-3R), which is in Phase II clinical trial for advanced hematologic cancers; SL-701, an immunotherapy to attack tumors that is in Phase II clinical trial; and SL-80...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
EAT $140.46	7.38%	Jun 05
TPR $140.47	3.67%	Jun 04
N NVRI $19.53	8.19%	May 20
SAP $172.39	3.79%	May 05
GLBE $31.61	2.44%	May 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by